Subchronic exposure to ellagic acid impairs cytotoxic T-cell function and suppresses humoral immunity in mice

Immunopharmacology and Immunotoxicology

Volumn 25, Issue 3, 2003, Pages 409-422

  Allen, C T ^a   Peden Adams, M M ^a,b   EuDaly, J ^a   Keil, D E ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Ellagic acid; Immunological function; Polyphenol

Indexed keywords

DNA; DRINKING WATER; ELLAGIC ACID; IMMUNOGLOBULIN M ANTIBODY; NICKEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL CYCLE; CELL FUNCTION; CHELATION; CYTOTOXIC T LYMPHOCYTE; DIET SUPPLEMENTATION; DNA METHYLATION; FEMALE; FOOD COMPOSITION; GRAPE; HUMORAL IMMUNITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUT; PLAQUE FORMING CELL; PRIORITY JOURNAL; RASPBERRY; REGULATORY MECHANISM; STRAWBERRY;

ANIMALS; ANTIBODY FORMATION; BODY WEIGHT; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; ELLAGIC ACID; FEMALE; IMMUNOGLOBULIN M; IMMUNOLOGIC FACTORS; KILLER CELLS, NATURAL; MICE; MICE, INBRED DBA; T-LYMPHOCYTES, CYTOTOXIC; TIME FACTORS;

ANIMALIA; FRAGARIA X ANANASSA; RUBUS GLAUCUS; VITACEAE; VITIS SP.;

EID: 0141758400     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.1081/IPH-120024508     Document Type: Article

References (43)

1. Daniel, E.M.; Ratnayake, S.; Kinstle, T.; Stoner, G.D. The effects of pH and rat intestinal contents on the liberation of ellagic acid from purified and crude ellagitannins. J. Natr. Prod. 1991, 54 (4), 946-952.
2. USDA Economic Research Service. Fruits and Tree Nuts: Situation and Outlook Yearbook; U.S. Department of Agriculture: Hyattsville, MD, 1988.
3. Shugart, L.; Kao, J. Effect of ellagic and caffeic acids on covalent binding of benzo[a]pyrene to epidermal DNA of mouse skin in organ culture. Int. J. Biochem. 1984, 16 (5), 571-573.
4. Barch, D.H.; Rundhaugen, L.M.; Stoner, G.D.; Pillay, N.S.; Rosche, W.A. Structure-function relationships of the dietary anticarcinogen ellagic acid. Carcinogen 1996, 17 (2), 265-269.
5. Castonguay, A.; Boukharta, M.; Teel, R. Biodistribution of, antimutagenic efficacies in Salmonella typhimurium of, and inhibition of P450 activities by ellagic acid and one analogue. Chem. Res. Toxicol. 1998, 11, 1258-1264.
6. Teel, R.W. Ellagic acid binding to DNA as a possible mechanism for its antimutagenic and anticarcinogenic action. Cancer Lett. 1986, 30, 329-336.
7. Mukhtar, H.; Mukul, D.; Bickers, D.R. Inhibition of 3-methylcholanthrene-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Res. 1986, 46, 2262-2265.
8. Ahn, D.; Putt, D.; Kresty, L.; Stoner, G.D.; Fromm, D.; Hollenberg, P.F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogen 1996, 17 (4), 821-828.
9. Barch, D.H.; Rundhaugen, L.M.; Thomas, P.E.; Kardos, P. Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA. Biochem. and Biophys. Res. Commun. 1994, 201 (3), 1477-1482.
10. Barch, D.H.; Rundhaugen, L.M. Ellagic acid induces NAD(P)H: quinone reductase gene. Carcinogen 1994, 15 (9), 2065-2068.
11. van Lieshout, E.M.M.; Bedaf, M.M.G.; Pieter, M.; Ekkel, C.; Nijoff, W.A. ; Peters, W.H.M. Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels. Carcinogen 1998, 19 (11), 2055-2057.
12. Dixit, R.; Gold, B. Inhibition of N-methyl-N-nitrosourea-induced mutagenicity and DNA methylation by ellagic acid. Proc. Natl. Acad. Sci. USA 1986, 83, 8039-8043.
13. 6-methylguanine by dietary ellagic acid in rats. Cancer Res. 1988, 48, 7088-7092.
14. Narayanan, B.A.; Geoffroy, O.; Willingham, M.C.; Re, G.G.; Nixon, D.W. P53/p21 (WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett. 1999, 136, 215-221.
15. Soni, K.B.; Lahiri, M.; Chackradio, P.; Bhide, S.V.; Kuttan, R. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett. 1997, 115, 129-133.
16. Kaul, A.; Khanduja, K.L. Plant polyphenols inhibit benzoyl peroxide-induced superoxide anion radical production and diacylglyceride formation I murine peritoneal macrophages. Nutr. Cancer. 1999, 35 (2), 207-211.
17. Bock, P.E.; Srinivasan, K.R.; Shore, J.D. Activation of intrinsic blood coagulation by ellagic acid: insoluble ellagic acid-metal ion complexes are the activating species. Biochemistry 1981, 20, 7258-7263.
18. Dow, R.L.; Chou, T.T.; Bechle, B.M.; Goddard, C.; Larson, E.R. Identification of tricyclic analogs related to ellagic acid as potent/selective tyrosine protein kinase inhibitors. J. Med. Chem. 1994, 37, 2224-2231.
19. Ahmed, S.; Rahman, A.; Saleem, M.; Athar, M.; Sultana, S. Ellagic acid ameliorates nickel induced biochemical alterations: diminution of oxidative stress. Human Exp. Toxicol. 1999, 18, 691-698.
20. Katiyar, S.K.; Challa, A.; McCormick, T.S.; Cooper, K.D.; Mukhtar, H. Prevention of UVB-induced immunosuppression in mice by the green tea polyphenol (-)-epigallo-catechin-3-gallate may be associated with alterations in IL-10 and IL-12 production. Carcinogen 1999, 20 (11), 2117-2124.
21. Katiyar, S.K.; Elmets, C.A.; Agarwal, R.; Mukhtar, H. Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem. Photobiol. 1995, 62 (5), 855-861.
22. Bhargava, U.C.; Westfall, B.A.; Siehr, D.J. Preliminary pharmacology of ellagic acid from Juglans nigra (black walnut). J. Pharm. Sci. 1968, 57, 1728-1732.
23. Duke, S.S.; Schook, L.B.; Holsapple, M.P. Effects of N-nitrosodimethylamine on tumor susceptibility. J. Leuk. Biol. 1985, 37, 383-394.
24. Bryant, J.; Day, R.; Whiteside, T.L.; Herberman, R.B. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. of Immunol. Methods 1992, 146, 91-103.
25. Murray, M.J; Lauer, L.D.; Luster, M.I.; Luebke, R.W.; Adams, D.O.; Dean, J.H. Correlation of murine susceptibility to tumor, parasite, and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate. Int. J. Immunopharmacol. 1985, 7, 491-500.
26. Jeme, N.K.; Nordin, A.A. Plaque formation in agar by single antibody producing cells. Science 1963, 140, 405.
27. Cunningham, A.J.; Szenberg, A. Further improvements in the plaque forming technique for detecting single antibody forming cells. Immunol. 1968, 14, 599-601.
28. Mukhtar, H.; Das, M.; Del Tito, B.J., Jr.; Bick; Bickers, D.R. Protection against 3-methylcholanthrene-induced skin tumorigenesis in BALB/C mice by ellagic acid. Biochem. and Biophys. Res. Commun. 1984, 119 (2), 751-757.
29. Wargovich, M.J. Experimental evidence for cancer preventive elements in foods. Cancer Lett. 1997, 114, 11-17.
30. Mandal, S.; Stoner, G.D. Inhibition of N-nitrosobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogen 1990, 11 (1), 55-61.
31. Stoner, G.D.; Morse, M.A. Isothiocyanates and plant polyphenols as inhibitors of lung and esophageal cancer. Cancer Lett. 1997, 114, 113-119.
32. Doyle, B.; Griffiths, L.A. The metabolism of ellagic acid in the rat. Xenobiotica 1980, 10 (4), 247-256.
33. Lawson, P.T. Ed. Rats. Assistant Laboratory Animal Technician Training Manual; American Association for Laboratory Animal Science: Chelsea, MI, 1998; 112.
34. Calabrese E.J. Overcompensation stimulation: a mechanism for hormetic effects. Crit. Rev. Toxicol. 2001, 31 (4-5), 425-470.
35. Rook, A.H.; Zaki, M.H.; Wysocka, M.; Wood, G.S; Duvic, M.; Showe, L.C.; Foss, F.; Shapiro, M.; Kuzel, T.M.; Olsen E.A.; Vonderheid, E.C.; Laliberte, R. ; Sherman, M.L. The role for interleukin-12 therapy of cutaneous T cell lymphoma. Ann. N.Y. Acad. Sci. 2001, 941, 177-184.
36. Imai, N.; Harashima, N.; Ito, M.; Miyagi, Y.; Harada, M.; Yamada, A.; Itoh, K. Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases. Int. J. Cancer 2001, 94 (2), 237-242.
37. Barouch, D.H.; Letvin, N.L. CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. Curr. Opin. Immunol. 2001, 13 (4), 479-482.
38. Baldridge, J.R.; Barry, R.A.; Hinrichs, D.J. Expression of systemic protection and delayed-type hypersensitivity to Listeria monocytogenes is mediated by different T-cell subsets. Infect. Immun. 1990, 58, 654-658.
39. Boes, M. Role of natural and immune IgM antibodies in immune responses. [Review] Mol. Immunol. 2000, 37 (18), 1141-1149.
40. Bachmann, M.F.; Kopf, M. The role of B cells in acute and chronic infections. Cur. Opin. Immunol. 1999, 11 (3), 332-339.
41. Klasse, P.J.; Sattentau, Q.J. Mechanisms of virus neutralization by antibody. Curr. Top. Microbiol. Immunol. 2001, 260, 87-108.
42. Blackwell, N.M.; Else, K.J. B cells and antibodies are required for resistance to the parasitic gastrointestinal nematode Trichuris muris. Infection & Immunity 2001, 69 (6), 3860-3868.
43. Planelles, L.; Thomas, M.C.; Alonso, C.; Lopez, M.C. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect. Immun. 2001, 69 (10), 6558-6563.